Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its versatile menu of biology engineering services. As a full-stack synthetic biology service ...

Ginkgo Bioworks draws attention as healthcare strength meets caution around synthetic biology, platform growth, and execution ...

Leveraging Ginkgo's plant-cell assay and engineering capabilities to aid Light Bio in optimizing the performance of its light-emitting plants The scientists at Light Bio have discovered a new type of ...

It has been difficult to be a shareholder of Ginkgo Bioworks (NYSE: DNA) over the past year. The stock has collapsed about 72% from its peak last summer. The company's cell engineering foundry is an ...

The company's cell engineering platform combines robotics and artificial intelligence (AI) to produce new cell lines for its clients. This is important because many top-selling drugs are manufactured ...

For now, that is. Sensible Biotechnologies, a startup based in Bratislava, Slovakia and Oxford in the U.K. has just announced a partnership with Ginkgo Bioworks that might just turn mRNA-based ...

Detailed price information for Ginkgo Bioworks Hldgs Inc (DNA-N) from The Globe and Mail including charting and trades.

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks, an organism design company, today announced that it has raised $45 million in an oversubscribed Series B round. Viking Global, a firm managing more than $30 ...